Navigation Links
Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
Date:6/25/2008

itive patients who were naive to antiretroviral treatment. Nine out of 12 patients in each of four cohorts received RDEA806. The primary efficacy end point was the change from baseline in plasma viral load. Top-line results from all four cohorts showed the following:

-- The median reduction in plasma viral load at nadir was 1.9 - 2.1 log copies/ml (placebo adjusted) for all four treatment cohorts.

-- Patients receiving either 800 mg or 1000 mg once daily with the enteric-coated tablet formulation, and patients receiving 400 mg twice daily with the capsule formulation, experienced a 1.8 - 1.9 log median reduction in plasma viral load (adjusted for placebo) on Day 8; the 600 mg capsule formulation given once daily produced a 1.4 log median reduction (adjusted for placebo) at this time point.

-- There were no serious adverse events, ECG-related adverse events, or drug-related rash reported in any cohort. The incidence of CNS side effects was similar between drug and placebo. Administration of the highest dose on an empty stomach showed an increase in gastrointestinal side effects, but these effects were generally transient and mild.

-- There were no premature discontinuations in any cohort.

-- Based on the results generated in this trial, the doses planned for the Phase 2b program will be 600 mg, 800 mg and 1000 mg once daily with the enteric-coated tablet given with or without food.

"We are very pleased to announce the successful completion of the Phase 2a program with RDEA806," said Barry D. Quart, PharmD, Ardea's President and CEO. "Based on the excellent antiviral activity observed with once-daily dosing of the enteric-coated oral formulation, we plan to proceed in the third quarter of this year with a multi-national Phase 2b study comparing 600 mg, 800 mg and 1000 mg once daily doses of RDEA806 to efavirenz (SUSTIVA(R)) in first-line patients receiving background treatment with Truvada(R) (emtricitabine and tenofovir)." '/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014  The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful PSE sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 32,105 boxes of ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 32,890 ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that ... in its catalogue: Personal Accident ... and Opportunities to 2018 ... report provides in depth market analysis, information ... and health insurance segment, including: - The ...
Breaking Medicine Technology:Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23
... Quest International, Inc., a leading global supplier ... announced the release of the AlphaView® AVC4, a color ... a 30 inch diagonal, 4-megapixel (MP) medical-grade LCD designed ... System (PACS) and radiology, where a high quality and ...
... 17, 2011 Panmira Pharmaceuticals, LLC, today ... executive officer. Until recently, Dr. Kumar served as chief ... transaction with Bristol-Myers Squibb Inc. for the sale of ... his team will oversee efforts on Panmira,s inflammation portfolio, ...
Cached Medicine Technology:Quest Introduces Its Next Generation AlphaView 4MP Medical LCD 2
(Date:8/21/2014)... 2014 Prosthodontists Dr. Saj Jivraj of the ... to provide workshops on full mouth rehabilitation. , Dr. Jivraj ... Bangalore in late September. , “Full mouth rehabilitation isn’t about ... making sure all of the elements of the mouth – ... together.” , Dr. Jivraj, who has traveled to India to ...
(Date:8/21/2014)... IA (PRWEB) August 21, 2014 Hope ... supermarket chain in the Midwest, for their continued support ... already donated more than $46K to Hope For The ... “Round Up” program. The company will continue this program ... For The Warriors®is a nonprofit dedicated to enhancing the ...
(Date:8/21/2014)... HIPAA Secure Now! rolled out its EHR (electronic ... vendors to now offer their customers a HIPAA security ... , HIPAA Secure Now! provides risk analysis services, ... U.S. The company assesses the risks of storing and ... and device used by the practice. , HIPAA ...
(Date:8/21/2014)... CA (PRWEB) August 21, 2014 If chocolate ... Tracie Crisafulli will soon be very happy and healthy. Tracie ... Nurse A Break ” contest. She and three of her ... $5,500, to luxuriate at the world-famous Chocolate Spa® at The ... in her third year working in the ambulatory surgery center ...
(Date:8/21/2014)... August 21, 2014 AttorneyOne.com, a recognized ... the latest information from the FDA on Dianeal ... US FDA announced on August 15, that two lots ... 2.5% Dextrose 5000mL (Ambu-Flex II), by Baxter International Inc., ... particulate matter. , The reason for the recall ...
Breaking Medicine News(10 mins):Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 2Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 3Health News:Oxnard Cosmetic Dentist Earns Invitation to Speak in India 4Health News:Hope For The Warriors Thanks Hy-Vee for Strong Support to Military 2Health News:Hope For The Warriors Thanks Hy-Vee for Strong Support to Military 3Health News:HIPAA Secure Now! Ramps up EHR Partner Program, Helps Healthcare Providers Achieve Meaningful Use under Revised CMS Deadlines 2Health News:Connecticut Nurse Wins a Sweet Prize from California Casualty 2Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2
... of the Program on Patients & Businesses Nationwide in ... and Human ServicesWASHINGTON, April 16 In a letter ... Congress urged the White House Office of Health Reform, ... U.S. Department of Health and Human Services to review ...
... Operating Loss Improves by 55% to $19.9 Million Compared ... Operations: Team to Co-locate in San Diego SAN DIEGO, ... AMLN ) today reported financial results for the quarter ... of $193.7 million for the quarter ended March 31, ...
... , , THURSDAY, April 16 (HealthDay News) -- Most Americans say ... of licensed drivers are registered to do so, a new ... wanted to donate their organs after death, even if their ... adults conducted in February by Astellas Pharma US and Donate ...
... With so many people out of work, each day, ... (SSDI). In response to this, FDP Inc. has assembled a ... the SSDI maze. With average waiting times of one ... minimize their disabilities and take any job they can find. ...
... and Grain-free Lamb & Apples WellBars Guaranteed to Make Dogs ... loving and responsible pet parents who want to show their ... of Wellness WellBars flavors to choose ... pets today announces the availability of two NEW ...
... New Bellevue Community Marks 12th in AreaBELLEVUE, Wash., April 16 ... that it has to offer in the senior years and ... leader in senior living and assisted living communities, is answering ... by building a community in a prime location that embraces ...
Cached Medicine News:Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 2Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 3Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 4Health News:84 Members of Congress, Led by Rep. Betty Sutton, Urge Policymakers to Rescind Controversial Medicare 'Competitive' Bidding Rule Before April 18 Deadline 5Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 2Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 3Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 4Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 5Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 6Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 7Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 8Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 9Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 10Health News:Amylin Pharmaceuticals Reports First Quarter Financial Results 11Health News:Survey Shows Many Want to Donate Organs, But Few Do 2Health News:Social Security Attorney Directory Helps to Speed SSDI Benefits 2Health News:New Wellness(R) WellBars(R) Dog Snack Flavors Receive a Round of 'Paw-pplause' 2Health News:Aegis of Bellevue, the Finest in Senior Living Communities 2Health News:Aegis of Bellevue, the Finest in Senior Living Communities 3
The Perkins has been established for well over 20 years as a "world standard" for hand held applanation tonometers....
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
... Sun Med TruFlow™ Oxygen flowmeter with ... lifetime warranty covering calibration and manufacturing defects. ... to meet most needs. Also available with ... auxiliary power take-off and double unit configurations. ...
... Sun Med TruFlow™ Oxygen flowmeter with ... lifetime warranty covering calibration and manufacturing defects. ... to meet most needs. Also available with ... auxiliary power take-off and double unit configurations. ...
Medicine Products: